Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhe Sheng

Showing results (381-390 of 669) with videos related to

Pageof 67
Sort By:
Molecules (Basel, Switzerland)|September 21, 2016
Osimertinib (AZD9291), a Mutant-Selective EGFR Inhibitor, Reverses ABCB1-Mediated Drug Resistance in Cancer CellsXiao-Yu Zhang, Yun-Kai Zhang, Yi-Jun Wang, et al.
European Journal of Pharmacology|April 8, 2014
Acerinol, a cyclolanstane triterpenoid from Cimicifuga acerina, reverses ABCB1-mediated multidrug resistance in HepG2/ADM and MCF-7/ADR cellsDao-Lu Liu, Ying-Jie Li, Nan Yao, et al.
Oncotarget|April 15, 2015
Tyrosine-protein phosphatase non-receptor type 12 expression is a good prognostic factor in resectable non-small cell lung cancerXun Cao, Yan-Zhen Chen, Ruo-Zhen Luo, et al.
Journal of Cancer|May 22, 2023
Differentiation of imatinib -resistant chronic myeloid leukemia cells with BCR-ABL-T315I mutation induced by Jiyuan Oridonin AYun Xu, Ziting Wang, Lei Zhang, et al.
Chinese Journal of Cancer|May 13, 2015
ATP-binding cassette subfamily B member 1 (ABCB1) and subfamily C member 10 (ABCC10) are not primary resistance factors for cabazitaxelRishil J Kathawala, Yi-Jun Wang, Suneet Shukla, et al.
Oncotarget|August 23, 2015
Semi-synthetic ocotillol analogues as selective ABCB1-mediated drug resistance reversal agentsYun-Kai Zhang, Hengyuan Zhang, Guan-Nan Zhang, et al.
Translational Neurodegeneration|January 17, 2025
Correction: CD2AP deficiency aggravates Alzheimer's disease phenotypes and pathology through p38 MAPK activationYan-Yan Xue, Zhe-Sheng Zhang, Rong-Rong Lin, et al.
Recent Patents on Anti-Cancer Drug Discovery|May 20, 2025
B-9-8, a Novel Harman Dimer, Reverses ABCG2-mediated Chemotherapeutic Drug ResistanceRuiqiang Zhao, Yan Wen, Chao-Yun Cai, et al.
Gastroenterology Report|January 14, 2021
Multifaceted anti-colorectal tumor effect of digoxin on HCT8 and SW620 cells <i>in vitro</i>Yong-Qiang Hou, Ying-Ying Wang, Xing-Can Wang, et al.
International Journal of Molecular Sciences|August 25, 2019
Chk1 Inhibitor MK-8776 Restores the Sensitivity of Chemotherapeutics in P-glycoprotein Overexpressing Cancer CellsQingbin Cui, Chao-Yun Cai, Jing-Quan Wang, et al.
Pageof 67

Showing results (381-390 of 669) with videos related to

Sort By:
Pageof 67
Molecules (Basel, Switzerland)|September 21, 2016
Osimertinib (AZD9291), a Mutant-Selective EGFR Inhibitor, Reverses ABCB1-Mediated Drug Resistance in Cancer CellsXiao-Yu Zhang, Yun-Kai Zhang, Yi-Jun Wang, et al.
European Journal of Pharmacology|April 8, 2014
Acerinol, a cyclolanstane triterpenoid from Cimicifuga acerina, reverses ABCB1-mediated multidrug resistance in HepG2/ADM and MCF-7/ADR cellsDao-Lu Liu, Ying-Jie Li, Nan Yao, et al.
Oncotarget|April 15, 2015
Tyrosine-protein phosphatase non-receptor type 12 expression is a good prognostic factor in resectable non-small cell lung cancerXun Cao, Yan-Zhen Chen, Ruo-Zhen Luo, et al.
Journal of Cancer|May 22, 2023
Differentiation of imatinib -resistant chronic myeloid leukemia cells with BCR-ABL-T315I mutation induced by Jiyuan Oridonin AYun Xu, Ziting Wang, Lei Zhang, et al.
Chinese Journal of Cancer|May 13, 2015
ATP-binding cassette subfamily B member 1 (ABCB1) and subfamily C member 10 (ABCC10) are not primary resistance factors for cabazitaxelRishil J Kathawala, Yi-Jun Wang, Suneet Shukla, et al.
Oncotarget|August 23, 2015
Semi-synthetic ocotillol analogues as selective ABCB1-mediated drug resistance reversal agentsYun-Kai Zhang, Hengyuan Zhang, Guan-Nan Zhang, et al.
Translational Neurodegeneration|January 17, 2025
Correction: CD2AP deficiency aggravates Alzheimer's disease phenotypes and pathology through p38 MAPK activationYan-Yan Xue, Zhe-Sheng Zhang, Rong-Rong Lin, et al.
Recent Patents on Anti-Cancer Drug Discovery|May 20, 2025
B-9-8, a Novel Harman Dimer, Reverses ABCG2-mediated Chemotherapeutic Drug ResistanceRuiqiang Zhao, Yan Wen, Chao-Yun Cai, et al.
Gastroenterology Report|January 14, 2021
Multifaceted anti-colorectal tumor effect of digoxin on HCT8 and SW620 cells <i>in vitro</i>Yong-Qiang Hou, Ying-Ying Wang, Xing-Can Wang, et al.
International Journal of Molecular Sciences|August 25, 2019
Chk1 Inhibitor MK-8776 Restores the Sensitivity of Chemotherapeutics in P-glycoprotein Overexpressing Cancer CellsQingbin Cui, Chao-Yun Cai, Jing-Quan Wang, et al.
Pageof 67